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Background: There is substantial international variation in mortality after abdominal aortic aneurysm
(AAA) repair; many non-operative factors influence risk-adjusted outcomes. This study compared 90-day
and 5-year mortality for patients undergoing elective AAA repair in England and Sweden.
Methods: Patients were identified from English Hospital Episode Statistics and the Swedish Vascu-
lar Registry between 2003 and 2012. Ninety-day mortality and 5-year survival were compared after
adjustment for age and sex. Separate within-country analyses were performed to examine the impact
of co-morbidity, hospital teaching status and hospital annual caseload.
Results: The study included 36 249 patients who had AAA treatment in England, with a median age of
74 (i.q.r. 69–79) years, of whom 87⋅2 per cent were men. There were 7806 patients treated for AAA in
Sweden, with a median of age 73 (68–78) years, of whom 82⋅9 per cent were men. Ninety-day mortality
rates were poorer in England than in Sweden (5⋅0 versus 3⋅9 per cent respectively; P<0⋅001), but were
not significantly different after 2007. Five-year survival was poorer in England (70⋅5 versus 72⋅8 per cent;
P< 0⋅001). Use of EVAR was initially lower in England, but surpassed that in Sweden after 2010. In both
countries, poor outcome was associated with increased age. In England, institutions with higher operative
annual volume had lower mortality rates.
Conclusion: Mortality for elective AAA repair was initially poorer in England than Sweden, but improved
over time alongside greater uptake of EVAR, and now there is no difference. Centres performing a greater
proportion of EVAR procedures achieved better results in England.
Presented to the Annual Meeting of the British Society for Endovascular Therapy, Wotton-under-Edge, UK, June
2017; published in abstract form as Eur J Vasc Endovasc Surg 2017; 54: 667
Paper accepted 9 October 2017
Published online in Wiley Online Library (www.bjs.co.uk). DOI: 10.1002/bjs.10749
Introduction
Perioperative mortality remains the key benchmark for
patients offered elective abdominal aortic aneurysm (AAA)
repair. There is substantial international variation in mor-
tality from AAA1, and many non-operative factors may
influence risk-adjusted outcomes. Endovascular aneurysm
repair (EVAR) provides safer short-term results than open
surgery2–5, but the availability of this technology varies.
Both the use of EVAR and the outcomes of vascular surgery
are known to vary between hospitals and countries6,7, and
benchmarking of institutional and national data is required
to provide perspective for the increasing trend to pub-
lish mortality results in the public domain. Comparative
analysis of international data can highlight factors that
are associated with best practice and aid the formula-
tion of strategies to improve patient care or the equity
of service provision. Existing international comparisons
have reported in-hospital mortality8. Multiple studies have
shown that there is an increased mortality risk approxi-
mately 90 days after aortic surgery, which is a reason to
evaluate 90-day rather than 30-day or in-hospital mortal-
ity for short-term results9. From the patient’s perspective,
however, the durability of repair and long-term survival are
of greater importance10,11.
The objective of this work was to study differences and
time trends in short-term (90 days) and long-term (5 years)
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Table 1 Descriptive results for elective abdominal aortic aneurysm repair in England and Sweden
England Sweden P*
(n=36249) (n=7806)
No. of patients undergoing EVAR 14226 (39⋅3) 3705 (47⋅5) < 0⋅001
30-day mortality 1237 (3⋅4) 183 (2⋅3) <0⋅001
Open repair 1042 of 22 023 (4⋅7) 129 of 4101 (3⋅1) < 0⋅001
EVAR 195 of 14 226 (1⋅4) 54 of 3705 (1⋅5) 0⋅747
90-day mortality 1812 (5⋅0) 304 (3⋅9) <0⋅001
Open repair 1423 of 22 023 (6⋅5) 195 of 4101 (4⋅8) < 0⋅001
EVAR 389 of 14 226 (2⋅7) 109 of 3705 (2⋅9) 0⋅530
5-year survival (%) 70⋅5 72⋅8 <0⋅001
Teaching hospitals in analysis 31 of 157 (19⋅7) 9 of 37 (24) 0⋅694
No. of AAAs treated in teaching hospital 8511 (23⋅4) 3797 of 7754 (49⋅0) <0⋅001
Values in parentheses are percentages. EVAR, endovascular aneurysm repair; AAA, abdominal aortic aneurysm. *χ2 test.
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Fig. 1 Ninety-day mortality after elective abdominal aortic aneurysm repair in England and Sweden. Values are means with 95 per cent
confidence intervals
mortality after elective AAA repair in two European coun-
tries, with special focus on the importance of uptake of
EVAR and centralization to high-volume centres. There
are few similar international comparative studies6,12.
Methods
Demographic and in-hospital outcome data were extracted
from Hospital Episode Statistics (HES) in England, and
the Swedish Vascular Registry (Swedvasc) for all patients
undergoing elective infrarenal AAA repair between 1
January 2003 and 31 December 2012. HES is the admin-
istrative data set for the English National Health Service
(NHS) and describes every admission to an English
hospital. Swedvasc is based on prospectively collected
data, with nationwide coverage. Both data sets have been
subject to extensive internal and external studies of data
quality9,13–15, and shown excellent validity. Accurate
long-term survival data were available through the linkage
of both countries’ data sets to the national (government)
population registry, obviating the problem with loss to
follow-up in the analysis of long-term survival.
The inclusion criteria comprised: patients undergoing
elective infrarenal AAA repair, defined by an elective mode
of admission and ICD-10 or OPCS-4 codes in HES; and
according to predefined variables in the Swedvasc database.
EVAR and open AAA repairs were identified according to
previously published methodology for HES and Swedvasc.
The primary outcome measures were 90-day and 5-year
mortality after open or endovascular repair, with outcomes
considered separately for three age groups (less than 70
years, 70–79 years and 80 years or more). Secondary out-
come measures included the proportion of patients man-
aged by EVAR, outcomes in teaching versus non-teaching
hospitals, and outcomes for hospitals with varying annual
caseload (volume) for AAA repair.
Patient- and hospital-level factors were extracted to
enable comparable risk adjustment in bothHES and Swed-
vasc data. Pre-existing co-morbidity was defined sepa-
rately for Sweden and England, with techniques validated
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Fig. 2 Five-year survival after elective abdominal aortic aneurysm repair in England and Sweden, adjusted for age and sex in both
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Fig. 3 Use of endovascular aneurysm repair (EVAR) and 90-day mortality in England and Sweden during the study
independently for each country, using the variables avail-
able within the Swedvasc data set, and separate compo-
nents of the Royal College of Surgeons’ modified Charlson
Index for HES16. Hospital factors included bed capacity,
teaching status and institutional annual volume (caseload)
for AAA repair. Hospital teaching status and bed capacity
were classified for English hospitals from publicly avail-
able data. Institutional volume (caseload) for AAA repair
was represented using previously defined methodology for
quintile analysis17. The quintiles comprised five groups of
institutions in each country, arranged by the number of
AAA repairs undertaken per year; each quintile contained
a similar number of patients. They were created to ensure
that all hospitals of a particular annual operative caseload
were grouped together, rather than splitting hospitals of
the same annual volume to create exactly the same num-
ber of patients in each quintile. A sensitivity analysis was
carried out by merging both data sets and calculating the
mean number of operations per hospital per year, with clas-
sification of the quintiles based on the overall volume per
hospital in both countries. Owing to potentially system-
atic differences in diagnostic coding between England and
Sweden, risk adjustment for co-morbidity was used only for
within-country analysis, rather than for comparative anal-
ysis between countries.
Statistical analysis
Primary and secondary outcomes weremodelled separately
for HES and Swedvasc data. Binary logistic regression
was used for within-country analysis of 90-day mortal-
ity, whereas Cox regression analysis was used to assess
the 5-year mortality. Backward selection procedures were
used with comparison of models by means of the likeli-
hood ratio test to ascertain whether individual co-variables
improved goodness of fit. The selection process was based
on models that included all potential predictor variables
© 2018 The Authors. BJS published by John Wiley & Sons Ltd www.bjs.co.uk BJS
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Table 2 Multivariable logistic regression analysis of predictors of
90-day mortality in England
Odds ratio P
Age <0⋅001
Sex (F versus M) 1⋅14 (1⋅00, 1⋅30) 0⋅045
Year of operation* <0⋅001
2003–2004 versus 2005–2008 1⋅20 (1⋅07, 1⋅36)
2005–2008 versus 2009–2012 1⋅38 (1⋅23, 1⋅56)
Hospital volume (quintiles 1–4 versus 5)*† 1⋅54 (1⋅39, 1⋅71) <0⋅001
Teaching hospital (no versus yes) 0⋅99 (1⋅11, 0⋅88) 0⋅892§
No. of co-morbidities‡ <0⋅001
>3 versus 3 1⋅83 (1⋅40, 2⋅41)
3 versus 2 1⋅21 (1⋅02, 1⋅44)
2 versus 0–1 1⋅41 (1⋅27, 1⋅57)
Type of repair <0⋅001
Type of repair by age (open repair versus
EVAR)*
0⋅004
Age<70 years 1⋅69 (1⋅37, 2⋅24)
Age 70–79 years 2⋅73 (2⋅41, 3⋅14)
Age ≥ 80 years 2⋅99 (2⋅57, 3⋅49)
Values in parentheses are 95 per cent confidence intervals. *Orthogonal
contrasts were calculated where possible to establish the differences
between categories. †Hospital volume was analysed in quintiles based on
annual number of intact abdominal aortic aneurysm repairs; quintile 5
had the highest volume. ‡Assessed according to Royal College of
Surgeons’ modified Charlson Index. EVAR, endovascular aneurysm
repair. §P value before being out of the model.
Table 3 Multivariable logistic regression analysis of predictors of
90-day mortality in Sweden
Odds ratio P
Age < 0⋅001
Sex (F versus M) 1⋅37 (0⋅99, 1⋅89) 0⋅054
Year of operation* < 0⋅001
2003–2005 versus 2006–2007 1⋅33 (1⋅14, 1⋅56)
2006–2007 versus 2008–2009 0⋅75 (0⋅64, 0⋅89)
2008–2009 versus 2010–2012 1⋅29 (1⋅10, 1⋅51)
Hospital volume (quintiles)*† < 0⋅001
1–2 versus 4–5 0⋅60 (0⋅38, 0⋅95)
1–2 versus 3 1⋅81 (1⋅08, 3⋅03)
Teaching hospital (no versus yes) 1⋅66 (1⋅11, 2⋅50) 0⋅015
Type of repair < 0⋅001
Type of repair by age (open repair versus
EVAR)*
0⋅019
Age<70 years 0⋅98 (0⋅60, 1⋅83)
Age 70–79 years 2⋅18 (1⋅51, 3⋅03)
Age ≥ 80 years 3⋅17 (0⋅90, 4⋅77)
Values in parentheses are 95 per cent confidence intervals. *Orthogonal
contrasts were calculated when possible to establish the differences
between categories. †Hospital volume was analysed in quintiles based on
annual number of intact abdominal aortic aneurysm repairs; quintile 5
had the highest volume. EVAR, endovascular aneurysm repair.
without univariable preselection, followed by backward
selection. Co-variables considered for modelling included
endovascular repair, age, sex, co-morbidity, hospital
procedural volume (caseload), hospital bed capacity and
Table 4 Cox regression analysis of factors influencing 5-year
survival in England
Hazard ratio P
Age (per year) < 0⋅001
Sex (F versus M) 1⋅09 (0⋅95, 1⋅25) 0⋅209§
Year of operation* < 0⋅001
2003–2005 versus 2006–2008 1⋅11 (1⋅05, 1⋅18)
2006–2008 versus 2009–2010 1⋅19 (1⋅12, 1⋅26)
2009–2010 versus 2011 1⋅14 (1⋅03, 1⋅25)
2011 versus 2012 1⋅20 (1⋅04, 1⋅39)
Hospital volume (quintiles 1–4 versus 5)*† 1⋅10 (1⋅05, 1⋅16) 0⋅003
Teaching hospital (no versus yes) 0⋅94 (0⋅89, 0⋅99) 0⋅037
No. of co-morbidities‡ < 0⋅001
>3 versus 3 1⋅29 (1⋅14, 1⋅47)
3 versus 2 1⋅28 (1⋅19, 1⋅38)
2 versus 0–1 2⋅62 (1⋅49, 4⋅62)
Type of repair by age (open repair versus
EVAR)*
0⋅009
Age<70 years 0⋅85 (0⋅77, 0⋅94)
Age 70–79 years 1⋅01 (0⋅95, 1⋅07)
Age ≥ 80 years 0⋅99 (0⋅93, 1⋅05)
Values in parentheses are 95 per cent confidence intervals. *Orthogonal
contrasts were calculated when possible to establish the differences
between categories. †Hospital volume was analysed in quintiles based on
annual number of intact abdominal aortic aneurysm repairs; quintile 5
had the highest volume. ‡Assessed according to Royal College of
Surgeons’ modified Charlson Index. EVAR, endovascular aneurysm
repair. §P value before being out of the model.
Table 5 Cox regression analysis of factors influencing 5-year
survival in Sweden
Hazard ratio P
Age < 0⋅001
Sex (F versus M) 1⋅09 (0⋅95, 1⋅25) 0⋅209‡
Year of operation* 0⋅001
2003–2005 versus 2006–2007 1⋅33 (1⋅14, 1⋅56)
2006–2007 versus 2008–2009 0⋅75 (0⋅64, 0⋅89)
2008–2009 versus 2010–2012 1⋅29 (1⋅10, 1⋅51)
Hospital volume (quintiles 1–3 versus
4–5)*†
0⋅84 (0⋅74, 0⋅95) 0⋅006
Teaching hospital (no versus yes) 1⋅66 (1⋅11, 2⋅50) 0⋅015
Type of repair by age (open repair versus
EVAR)*
0⋅004
Age<70 years 0⋅55 (0⋅46, 0⋅65)
Age 70–79 years 0⋅74 (0⋅66, 0⋅82)
Age ≥ 80 years 0⋅92 (0⋅77, 1⋅12)
Current smoker (yes versus no) 1⋅26 (0⋅95, 1⋅69) 0⋅114‡
Pulmonary disease (yes versus no) 1⋅79 (1⋅34, 2⋅39) < 0⋅001
Diabetes mellitus (yes versus no) 1⋅33 (0⋅89, 1⋅99) 0⋅165‡
Hypertension (yes versus no) 1⋅31 (0⋅99, 1⋅74) 0⋅535‡
Cardiovascular disease (yes versus no) 1⋅20 (0⋅83, 1⋅74) 0⋅328‡
Myocardial infarction (yes versus no) 1⋅31 (0⋅99, 1⋅73) 0⋅059‡
Renal disease (yes versus no) 2⋅47 (1⋅73, 3⋅52) < 0⋅001
Values in parentheses are 95 per cent confidence intervals. *Orthogonal
contrasts were calculated when possible to establish the differences
between categories. †Hospital volume was analysed in quintiles based on
annual number of intact abdominal aortic aneurysm repairs; quintile 5
had the highest volume. EVAR, endovascular aneurysm repair. ‡P value
before being out of the model.
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teaching status, geographical region and year of surgery.
These risk factors were included in the models as they were
reported to be important in the literature18–20.
It is acknowledged that estimates of the association
between type of operation performed (open repair or
EVAR) and mortality can be biased owing to confounding
by other co-variables in observational data. To adjust for
the propensity of patients to undergo open repair or EVAR,
the g-formula technique (a causal inference analysis)17,21
was employed for estimation of the odds ratio (OR) for the
association between type of surgery (open repair or EVAR)
and 90-day mortality. The g-formula is a standard applica-
tion of a propensity weighting technique that reduces the
impact of selection bias between EVAR and open repair.
Confidence limits were estimated using bootstrapping
with 1000 samples in each country. Age- and sex-matched
analyses were undertaken to compare English and Swedish
outcomes for 90-day or 5-year mortality after both EVAR
and open repair, with focused analysis for patients aged 80
years or older and those younger than 80 years. HES and
Swedvasc data sets were linked using common variables,
and stratified for sex and 5-year age groups. A conditional
logistic regression analysis was performed incorporating
the strata as a blocking variable, to report the adjusted
difference between England and Sweden.
P< 0⋅050 was regarded as statistically significant. All
analyses were carried out using SAS® version 9.3 (SAS
Institute, Cary, North Carolina, USA) and R software (R
Foundation for Statistical Computing, Vienna, Austria).
Results
Elective AAA repair was done in 36 249 patients in England
and 7806 in Sweden during the study interval. In England,
the median age was 74 (i.q.r. 69–79) years and 87⋅2 per
cent were men. In Sweden, the median age was 73 (68–78)
years and 82⋅9 per cent were men. During the study, the
rate of elective AAA repair recorded in England was 26⋅68
per 100 000 population in 2003 and 33⋅08 per 100 000 in
2012. For Sweden, the rate of elective AAA repair was
28⋅81 and 36⋅97 per 100 000 population in 2003 and 2012
respectively. Further information on the annual rates of
elective AAA repair is provided in Table S1 (supporting
information).
Comparative 90-day mortality and 5-year survival
The crude 90-day mortality rate was greater after AAA
repair in England compared with Sweden (5⋅0 versus 3⋅9
per cent respectively; P< 0⋅001) (Table 1). Overall age and
sex-adjusted 90-day mortality was greater in England (OR
1⋅36, 95 per cent c.i. 1⋅20 to 1⋅54; P< 0⋅001) (Fig. 1).
Ninety-day mortality was worse in England than Sweden
for open repair (OR 1⋅40, 1⋅20 to 1⋅63; P< 0⋅001), but
similar after EVAR (OR 0⋅93, 0⋅75 to 1⋅16; P= 0⋅530)
(Table 1).
Five-year survival rates were worse in England than in
Sweden: 70⋅5 (95 per cent c.i. 70⋅0 to 71⋅1) versus 72⋅8 (71⋅7
to 73⋅9) per cent (P< 0⋅001). This difference persisted after
matching for age and sex (hazard ratio (HR) 1⋅08, 95 per
cent c.i. 1⋅03 to 1⋅14; P= 0⋅002). Subgroup analysis demon-
strated a difference in life expectancy for patients undergo-
ing open repair in England compared with Sweden (HR
1⋅22, 1⋅13 to 1⋅31; P< 0⋅001) but not for those undergoing
EVAR (HR 1⋅01, 0⋅94 to 1⋅08; P= 0⋅899) (Fig. 2; Fig. S1,
supporting information).
Increased use of EVAR in England over time coin-
cided with a reduced difference in 90-day mortality,
such that a sensitivity analysis for 90-day mortality in
England compared with Sweden by year (adjusted in
accordance with previous logistic models for 90-day mor-
tality) demonstrated no significant difference between the
countries from 2007 to 2012 (Fig. 3; Fig. S2, supporting
information).
Secondary outcomes
The overall use of EVAR was greater in Sweden (47⋅5
per cent versus 39⋅1 per cent in England) but increased
considerably in England during the study (Fig. 3), and even
surpassed that in Sweden between 2010 and 2012. EVAR
was used in the majority of AAA repairs in both countries
after 2009.
In both England and Sweden, factors associated with
90-day mortality were increasing age, female sex and use
of open repair (Tables 2 and 3). Five-year survival was
associated with age at surgery and year of surgery in both
countries (Tables 4 and 5).
In both countries, quintiles of hospital volume were
distributed at similar intervals, with low-volume hospitals
in England performing 14 or fewer AAA repairs per annum
and those in Sweden undertaking ten or fewer AAA repairs
per annum, and high-volume hospitals carrying out at
least 67 and at least 55 AAA repairs annually respectively
(Table S2, supporting information). Thirty-daymortality by
hospital caseload for each country is shown inTable S3 (sup-
porting information). In England, institutions with a high
annual volume had lower 90-day and 5-year mortality. The
sensitivity analysis, with definition of quintiles based on
overall volumes in both countries, resulted in an increased
number of high-volume centres in England, as the
threshold for highest-volume centres was set at 60 pro-
cedures (Table S4, supporting information). This analysis
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confirmed the association between volume and outcome
in England for both 90-day mortality (P< 0⋅001) and
5-year mortality (P= 0⋅017), but did not find a signifi-
cant association in Sweden (Tables S5 and S6, supporting
information).
Analysis of outcomes by age revealed that 90-day mor-
tality was worse in England than Sweden both for patients
aged less than 80 years (OR 1⋅33, 95 per cent c.i. 1⋅14 to
1⋅54; P< 0⋅001) and those aged 80 years or more (OR 1⋅30,
1⋅03 to 1⋅64; P= 0⋅028) (Table S7, supporting information).
There was no difference in outcome after EVAR between
England and Sweden in these age groups (P= 0⋅640 and
P= 0⋅828 respectively). In patients younger than 80 years,
open repair was associated with higher mortality in Eng-
land than in Sweden (OR 1⋅61, 1⋅29 to 2⋅01; P< 0⋅001),
but there was no difference in outcome after open repair
between the two countries in those aged 80 years or more
(P= 0⋅533). Five-year survival after open surgery was worse
in England than Sweden for patients younger than 80 years
(HR 1⋅23, 1⋅13 to 1⋅34; P< 0⋅001).
There was a statistically significant interaction between
age and type of surgery: EVAR or open AAA repair.
Ninety-day mortality in England was significantly better
for EVAR than open repair in all age groups. In Sweden,
90-day mortality after EVAR was significantly better than
open repair in the 70–79-year age group. Five-year survival
was significantly worse after EVAR than open repair among
patients younger than 70 years in England and those aged
less than 80 years in Sweden (Tables 2–5).
Discussion
In this study, the short- and long-term outcomes of AAA
repair were analysed for a 10-year national cohort of
patients in two European countries with similar health-
care systems. The main finding was that 90-day and 5-year
outcomes for elective AAA repair were significantly bet-
ter in Sweden than in England. This appeared partially
attributable to the poor outcome of open repair in England,
where introduction of EVAR occurred later than in Swe-
den. In both countries, better results were seen each year. In
England, institutions performing greater numbers of AAAs
repair per annum had lowermortality rates. In recent years,
the use of EVAR has increased dramatically in England,
where up to 60 per cent of repairs currently are performed
with the endovascular technique. This is most likely the
main explanation for the observed reduction in mortality
over time, with abolition of any difference between Eng-
land and Sweden after 2007.
Increased perioperative mortality after AAA repair
in England compared with other countries has been
documented previously in registry-based analyses using
data from the UK National Vascular Database6,22. How-
ever, this finding has been criticized owing to potential
case selection in early iterations of the database, which was
previously based on voluntary registration. The present
report confirms the previous finding using HES data for
England with linked data for long-termmortality, allowing
long-term comparison of two full national cohorts of
patients. Additionally, this report shows that the perioper-
ative mortality difference between England and Sweden is
sustained up to 5 years after repair. The fact that long-term
survival curves are virtually parallel (Fig. 2), contradicts
the suggestion that eventual differences in case-mix can
explain the difference in short-term outcomes.
Although it was not possible to analyse the mean AAA
diameter in each country, previous publications23,24 showed
that the mean diameter of treated AAA between 2005
and 2013 was 6⋅2 cm in Sweden, whereas it was 6⋅6 cm
in the UK. In Sweden 20⋅5 per cent of patients had AAA
repair at a diameter less than 5⋅5 cm, compared with only
9⋅2 per cent in the UK. Part of this difference could be
explained by the fact that Swedvasc did not differentiate
between treatment for iliac or aortic aneurysm. The higher
rate of small AAA repair in Sweden could partly explain
the better overall 90-day mortality and 5-year survival.
However, as this was not analysed, causality cannot be
inferred. Even though the overall results (after adjustment
for age and sex) showed a difference in mortality, the AAA
diameter size does not explain why there was no difference
in 90-day mortality between England and Sweden for the
years 2007–2012. This suggests that difference in size of
AAA diameter at repair is not the main reason for the
discrepancy between the two countries.
A potential confounder in long-term survival is differ-
ences in expected survival between countries. According
to Organisation for Economic Co-operation and Devel-
opment data25, the life expectancy of a 65-year-old is 18⋅6
years in the UK, compared with 18⋅8 years in Sweden for
men, and 20⋅9 versus 21⋅3 years for women25. Based on this
small difference, it is unlikely that general life expectancy
explains the differences between countries.
Another potential confounder is the way vascular surgery
services were arranged in each country. During the study,
vascular surgery in Sweden was already carried out by
vascular specialist centres. However, in England, pres-
sures to centralize vascular surgery started around 2007,
with initial processes starting around 200926,27 and further
remodelling around 201328. The present study showed
that, through increased use of EVAR in England between
2007 and 2012, the difference in 90-day mortality between
the two countries was abolished. High-volume centres in
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England had better 90-day mortality and 5-year survival
results, in line with previous studies29–31. Thus, centraliza-
tion, while improving service provision in England, could
have increased the rate of EVAR, abolishing the difference
in the 90-day mortality between the two countries after
2010. This effect was similarly demonstrated in a previous
study32 of mortality after ruptured AAA between the two
countries.
This study showed that 90-day mortality in women was
higher than among men in both countries. However, this
sex difference was not noted at 5 years. Although previ-
ous studies33,34 highlighted the higher initial perioperative
mortality in women, the 5-year mortality did not confirm
this34,35. This is possibly due to other competing factors,
including increasing age, co-morbidities and type of repair,
in line with other studies36.
Although short- and long-term mortality after intact
AAA repair was higher in England than in Sweden after
open repair, there was no difference after EVAR. Even
though young patients (aged under 70 years) had a survival
benefit from EVAR in the early postoperative period, these
patients had an increased long-term risk of death compared
with those in the same age cohort treated by open surgery.
There are several potential explanations for this finding,
including an effect of case selection, with younger patients
at higher operative risk being offered EVAR.
Perioperative and long-term outcomes were both
affected by hospital volume and teaching status. A recent
analysis of ruptured AAAmortality in Sweden and England
confirmed the same trend in terms of hospital volume and
outcome during the same time interval (2003–2012)32.
Limitations of this study include its retrospective nature,
and differences in the national databases included in the
report. The English HES is exposed to risks of coding vari-
ations. However, previous validations have underlined the
robustness of this database for analysis of AAA mortality32.
The Swedvasc database has been validated internally and
externally, with excellent results13,15. A further limitation
is the lack of standardized co-morbidity data, including
smoking habits. However, population-based data on smok-
ing status published by Eurostat37 in 2014 do not show
any difference between the two countries (Table S8, sup-
porting information). Lack of data on AAA diameter and
morphology, as well as cause of death, is another limitation.
These data are not available within nationally comprehen-
sive administrative data sets. Thus, comparison of patient
selection, anatomical suitability for EVAR and long-term
aortic-related death rate could not be carried out.
In both countries, better results from AAA repair were
seen each year, and in England institutions performing
greater numbers of AAA repair per annum had lower
90-day and 5-year mortality rates. These findings may
justify central funding for EVAR programmes to ensure
equity of access to endovascular technology. In younger
patients, long-term outcome was, however, inferior after
EVAR despite a short-term survival benefit, which may
question use of EVAR in treatment of patients with long
life expectancy.
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